1. Home
  2. TYRA vs STKL Comparison

TYRA vs STKL Comparison

Compare TYRA & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • STKL
  • Stock Information
  • Founded
  • TYRA 2018
  • STKL 1973
  • Country
  • TYRA United States
  • STKL United States
  • Employees
  • TYRA N/A
  • STKL N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • STKL Precious Metals
  • Sector
  • TYRA Health Care
  • STKL Basic Materials
  • Exchange
  • TYRA Nasdaq
  • STKL Nasdaq
  • Market Cap
  • TYRA 576.6M
  • STKL 506.5M
  • IPO Year
  • TYRA 2021
  • STKL N/A
  • Fundamental
  • Price
  • TYRA $9.52
  • STKL $6.09
  • Analyst Decision
  • TYRA Strong Buy
  • STKL Strong Buy
  • Analyst Count
  • TYRA 7
  • STKL 2
  • Target Price
  • TYRA $30.86
  • STKL $9.50
  • AVG Volume (30 Days)
  • TYRA 298.0K
  • STKL 1.3M
  • Earning Date
  • TYRA 05-08-2025
  • STKL 05-07-2025
  • Dividend Yield
  • TYRA N/A
  • STKL N/A
  • EPS Growth
  • TYRA N/A
  • STKL N/A
  • EPS
  • TYRA N/A
  • STKL N/A
  • Revenue
  • TYRA N/A
  • STKL $740,934,000.00
  • Revenue This Year
  • TYRA N/A
  • STKL $10.78
  • Revenue Next Year
  • TYRA N/A
  • STKL $8.39
  • P/E Ratio
  • TYRA N/A
  • STKL N/A
  • Revenue Growth
  • TYRA N/A
  • STKL 12.92
  • 52 Week Low
  • TYRA $6.42
  • STKL $3.65
  • 52 Week High
  • TYRA $29.60
  • STKL $8.11
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 45.60
  • STKL 63.68
  • Support Level
  • TYRA $8.88
  • STKL $5.70
  • Resistance Level
  • TYRA $9.68
  • STKL $6.29
  • Average True Range (ATR)
  • TYRA 0.64
  • STKL 0.22
  • MACD
  • TYRA -0.08
  • STKL -0.01
  • Stochastic Oscillator
  • TYRA 26.98
  • STKL 65.85

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

Share on Social Networks: